{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:16:49Z","timestamp":1794507409770,"version":"4.9.1"},"reference-count":49,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"North West Lung Centre Charity","award":["LT072, LT077, LT083"],"award-info":[{"award-number":["LT072, LT077, LT083"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,4,6]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite significant clinical improvements, there is evidence of persisting airway inflammation in people with cystic fibrosis (CF) established on elexacaftor\/tezacaftor\/ivacaftor (ETI) therapy. As CF is a multi-system disease, systemic immune profiles can reflect local inflammation within the lungs and other organs. Understanding systemic inflammation after ETI therapy may reveal important translational insights. This study aims to profile systemic inflammatory changes and relate these to the well-documented improvements observed with ETI therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-centre longitudinal study with 57 CF subjects initiating ETI therapy. All participants were Phe508del homozygous or Phe508del\/minimal function. Blood samples were collected pre-ETI and 3\u201312 months post-therapy initiation. Analyses included mass spectrometry-based proteomics, a multiplex immunoassay, and flow cytometry for peripheral immune cell counts and phenotype. Controls samples were provided by 29 age-matched healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Systemic inflammation reduced with ETI therapy; however, the immune profile remained distinct from healthy controls. ETI reduced neutrophil counts and was associated with a more mature, less inflammatory phenotype, as well as a shift towards an immune resolving state associated with increased CD206 expression. Cytokines known to influence neutrophil levels reduced with therapy. Despite ETI therapy, neutrophil and monocyte counts remained elevated compared with healthy controls. There was no obvious association between the ETI-related improvements in systemic inflammation and lung function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with CF showed evidence of persisting systemic inflammation despite ETI therapy, which may have long-term potentially adverse effects on respiratory and other organ systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2024-222242","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:10:15Z","timestamp":1748581815000},"page":"604-615","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of elexacaftor\/tezacaftor\/ivacaftor on systemic inflammation in cystic fibrosis"],"prefix":"10.1136","volume":"80","author":[{"given":"Rosemary E","family":"Maher","sequence":"first","affiliation":[{"name":"Centre for Proteome Research, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-6012","authenticated-orcid":false,"given":"Urszula M","family":"Cytlak-Chaudhuri","sequence":"additional","affiliation":[{"name":"Lydia Becker Institute for Immunology and Inflammation, University of Manchester, Manchester, UK"},{"name":"Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK"},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1196-3818","authenticated-orcid":false,"given":"Saad","family":"Aleem","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-4431","authenticated-orcid":false,"given":"Peter","family":"Barry","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-3965","authenticated-orcid":false,"given":"Daniel Paul","family":"Brice","sequence":"additional","affiliation":[{"name":"Lydia Becker Institute for Immunology and Inflammation, University of Manchester, Manchester, UK"},{"name":"Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK"},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-5941","authenticated-orcid":false,"given":"Eva","family":"Caama\u00f1o Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Computational Biology Facility, Liverpool Shared Research Facilities, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1628-8331","authenticated-orcid":false,"given":"Kimberley","family":"Driver","sequence":"additional","affiliation":[{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-8178","authenticated-orcid":false,"given":"Edward","family":"Emmott","sequence":"additional","affiliation":[{"name":"Centre for Proteome Research, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-9481","authenticated-orcid":false,"given":"Alexander","family":"Rothwell","sequence":"additional","affiliation":[{"name":"Computational Biology Facility, Liverpool Shared Research Facilities, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4261-6821","authenticated-orcid":false,"given":"Emily","family":"Smith","sequence":"additional","affiliation":[{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-2272","authenticated-orcid":false,"given":"Mark","family":"Travis","sequence":"additional","affiliation":[{"name":"Lydia Becker Institute for Immunology and Inflammation, University of Manchester, Manchester, UK"},{"name":"Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK"},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3367-5808","authenticated-orcid":false,"given":"Dave","family":"Lee","sequence":"additional","affiliation":[{"name":"Lydia Becker Institute for Immunology and Inflammation, University of Manchester, Manchester, UK"},{"name":"Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK"},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-6034","authenticated-orcid":false,"given":"Paul Stephen","family":"McNamara","sequence":"additional","affiliation":[{"name":"Department of Child Health (University of Liverpool), Institute in the Park, Alder Hey Children's Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4043-0323","authenticated-orcid":false,"given":"Ian","family":"Waller","sequence":"additional","affiliation":[{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-4928","authenticated-orcid":false,"given":"Jaclyn Ann","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-1055","authenticated-orcid":false,"given":"Andrew","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9008-2502","authenticated-orcid":false,"given":"Robert W","family":"Lord","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"2025081509100674000_80.9.604.1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26485"},{"key":"2025081509100674000_80.9.604.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"2025081509100674000_80.9.604.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2025081509100674000_80.9.604.4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur Respir J"},{"key":"2025081509100674000_80.9.604.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.10.019"},{"key":"2025081509100674000_80.9.604.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0507OC"},{"key":"2025081509100674000_80.9.604.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108835","article-title":"Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis","volume":"27","author":"Liou","year":"2024","journal-title":"iScience"},{"key":"2025081509100674000_80.9.604.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32542-3"},{"key":"2025081509100674000_80.9.604.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0675-0"},{"key":"2025081509100674000_80.9.604.10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/13993003.02096-2022","article-title":"Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis","volume":"61","author":"Dhote","year":"2023","journal-title":"Eur Respir J"},{"key":"2025081509100674000_80.9.604.11","doi-asserted-by":"publisher","DOI":"10.1002\/PPUL.26261"},{"key":"2025081509100674000_80.9.604.12","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219943"},{"key":"2025081509100674000_80.9.604.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304555","article-title":"Anti-inflammatory effects of elexacaftor\/tezacaftor\/ivacaftor in adults with cystic fibrosis heterozygous for F508del","volume":"19","author":"Jarosz-Griffiths","year":"2024","journal-title":"PLoS One"},{"key":"2025081509100674000_80.9.604.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23428","article-title":"Plasma levels of chemokines decrease during elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis","volume":"10","author":"Westh\u00f6lter","year":"2024","journal-title":"Heliyon"},{"key":"2025081509100674000_80.9.604.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-020-01341-z","article-title":"Validation of the portable Bluetooth\u00ae Air Next spirometer in patients with different respiratory diseases","volume":"21","author":"Exarchos","year":"2020","journal-title":"Respir Res"},{"key":"2025081509100674000_80.9.604.16","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96"},{"key":"2025081509100674000_80.9.604.17","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037"},{"key":"2025081509100674000_80.9.604.18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr597"},{"key":"2025081509100674000_80.9.604.19","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025081509100674000_80.9.604.20","unstructured":"Korotkevich G , Sukhov V , Budin N , et al . Fast gene set enrichment analysis. bioRxiv 2021;060012."},{"key":"2025081509100674000_80.9.604.21","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2025081509100674000_80.9.604.22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01872","article-title":"Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection","volume":"11","author":"Ndlovu","year":"2020","journal-title":"Front Immunol"},{"key":"2025081509100674000_80.9.604.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01737-9"},{"key":"2025081509100674000_80.9.604.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.05.007"},{"key":"2025081509100674000_80.9.604.25","doi-asserted-by":"crossref","first-page":"5270657","DOI":"10.1155\/2018\/5270657","article-title":"Circulating CD14(+)CD163(+)CD206(+) M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy","volume":"2018","author":"Hou","year":"2018","journal-title":"Mediators Inflamm"},{"key":"2025081509100674000_80.9.604.26","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw024"},{"key":"2025081509100674000_80.9.604.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.12.009"},{"key":"2025081509100674000_80.9.604.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2021.151497"},{"key":"2025081509100674000_80.9.604.29","first-page":"27","article-title":"Single-cell transcriptome profiling of sepsis identifies HLA-DR(low)S100A(high) monocytes with immunosuppressive function","volume":"10","author":"Yao","year":"2023","journal-title":"Mil Med Res"},{"key":"2025081509100674000_80.9.604.30","doi-asserted-by":"crossref","unstructured":"Matsushima K , Yang D , Oppenheim JJ . Interleukin-8: An evolving chemokine. Cytokine 2022;153. doi:10.1016\/j.cyto.2022.155828","DOI":"10.1016\/j.cyto.2022.155828"},{"key":"2025081509100674000_80.9.604.31","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200701000-00003"},{"key":"2025081509100674000_80.9.604.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.01.007"},{"key":"2025081509100674000_80.9.604.33","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000590"},{"key":"2025081509100674000_80.9.604.34","doi-asserted-by":"crossref","DOI":"10.1038\/srep33123","article-title":"Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions","volume":"6","author":"Sawant","year":"2016","journal-title":"Sci Rep"},{"key":"2025081509100674000_80.9.604.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.07.012"},{"key":"2025081509100674000_80.9.604.36","doi-asserted-by":"publisher","DOI":"10.1002\/PPUL.26261"},{"key":"2025081509100674000_80.9.604.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.02.010"},{"key":"2025081509100674000_80.9.604.38","doi-asserted-by":"crossref","unstructured":"Singh S , Longmate J , Onion D , et al . CD206 upregulation in monocytes within whole blood cultures correlates with lung function in cystic fibrosis: a pilot study. Respiratory Medicine [Preprint]. doi:10.1101\/2023.11.15.23298577","DOI":"10.1101\/2023.11.15.23298577"},{"key":"2025081509100674000_80.9.604.39","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00725-2022"},{"key":"2025081509100674000_80.9.604.40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/23120541.00318-2019","article-title":"Ivacaftor decreases monocyte sensitivity to interferon-\u03b3 in people with cystic fibrosis","volume":"6","author":"Hisert","year":"2020","journal-title":"ERJ Open Res"},{"key":"2025081509100674000_80.9.604.41","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0322LE"},{"key":"2025081509100674000_80.9.604.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35151-7"},{"key":"2025081509100674000_80.9.604.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2004.06.006"},{"key":"2025081509100674000_80.9.604.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.021"},{"key":"2025081509100674000_80.9.604.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173257","article-title":"Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity","volume":"12","author":"Hair","year":"2017","journal-title":"PLoS ONE"},{"key":"2025081509100674000_80.9.604.46","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20158"},{"key":"2025081509100674000_80.9.604.47","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2018-0114OC"},{"key":"2025081509100674000_80.9.604.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109130"},{"key":"2025081509100674000_80.9.604.49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1012310","article-title":"Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations","volume":"13","author":"Martin","year":"2022","journal-title":"Front Immunol"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:03:31Z","timestamp":1759928611000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,8,15]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/thorax-2024-222242"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222242","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}